Intensive Smoking Cessation Counseling for Patients With Cancer
Mené aux Etats-Unis entre 2013 et 2017 sur 303 fumeurs atteints d'un cancer récemment diagnostiqué, cet essai randomisé multicentrique compare l'efficacité, du point de vue de l'abstinence tabagique confirmée biochimiquement, de 2 interventions comportant des conseils pour arrêter de fumer et une médication
Smoking remains the leading cause of preventable death in the United States. Tobacco use increases the risk of multiple cancers, including lung, oropharyngeal, pancreas, bladder, stomach, and colon. Continued tobacco use following a cancer diagnosis increases the risk of cancer recurrence, new primary cancers, and adverse treatment-related outcomes, including postoperative pulmonary complications, poor surgical healing, and decreased response to chemotherapeutic drugs.In contrast, tobacco cessation after cancer diagnosis is often associated with improved quality of life, fewer complications related to cancer treatment, and longer survival. In a 2018 study, the prevalence of cigarette smoking among adult cancer survivors was 11.8%, and many cancer survivors who quit smoking after a diagnosis may resume smoking. Failure to address the unique challenges of cessation contributes to lack of success in initial cancer treatment due to ongoing smoking and has been associated with an estimated incremental cost of nearly $11 000 per year per smoking patient.
JAMA , éditorial, 2019